LAURAN MEJIA: Open Payments
NPI 1114358264 · PECATONICA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,444 in 201 payments from 16 companies in 2025. Trend: 2023 $105 · 2024 $301 · 2025 $3,444
Food & beverage: $3,444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $611 |
| Neurocrine BioSciences, Inc. | 28 | $457 |
| Teva Pharmaceuticals USA, Inc. | 18 | $331 |
| Lundbeck LLC | 15 | $281 |
| Supernus Pharmaceuticals, Inc. | 17 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $215 |
| Janssen Pharmaceuticals, Inc | 12 | $210 |
| Otsuka America Pharmaceutical, Inc. | 10 | $205 |
| Collegium Pharmaceutical, Inc. | 12 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $176 |
Products named: VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, AUSTEDO XR, Qelbree, CAPLYTA, Jornay PM, TRINTELLIX.
Industry payments across IL — which companies pay providers there.
